Group | Activation | Description |
---|---|---|
HUVEC-/PMN- | HUVEC 0 ng/ml LPS | Control (non-inflamed tissue) |
 | + PMN 0 ng/ml LPS |  |
HUVEC++/PMN- | HUVEC 100 ng/ml LPS | Maximal local inflammation |
 | + PMN 0 ng/ml LPS |  |
HUVEC++/PMN ++ | HUVEC 100 ng/ml LPS | Maximal systemical inflammation in the hyper-inflammatory stage of sepsis |
 | + PMN 100 ng/ml LPS |  |
HUVEC+/PMN- | HUVEC 10 ng/ml LPS | Submaximal local inflammation |
 | + PMN 0 ng/ml LPS |  |
HUVEC+/PMN + | HUVEC 10 ng/ml LPS | Submaximal systemical inflammation in the hypo-inflammatory stage of sepsis |
 | + PMN 10 ng/ml LPS |  |
HUVEC++/PMN++/PLT | HUVEC 100 ng/ml LPS | Maximal systemical inflammation and endothelial damage in the hyper-inflammatory stage of sepsis |
 | + PMN 100 ng/ml LPS |  |
HUVEC+/PMN+/PLT | HUVEC 10 ng/ml LPS | Submaximal systemical inflammation and endothelial damage in the hypo-inflammatory stage of sepsis |
 | + PMN 10 ng/ml LPS |  |